PS1449 DISSECTING THE THERAPEUTIC MECHANISM OF RUXOLITINIB IN JAK2V617F MEDIATED MPNS REVEALED AN INHIBITION OF BOTH ONCOGENIC AND NON-ONCOGENIC CELLS BY DOWN REGULATION OF INFLAMMATORY CYTOKINE LEVELS

Authors: S.P. G. Gorantla, T. Poggio, S. Saleem, R. Tritter, T. Müller, S. Gambheer, C. Dierks, J. Duyster

Published: 2019-06-17

DOI: 10.1097/01.hs9.0000564060.60522.a2

Source: Full article

---

Abstract

No abstract found.